These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4556666)

  • 21. Effect of normal serum and antithymocyte serum on Friend disease in mice.
    Larson CL; Ushijima RN; Baker RE; Baker MB; Gillespie CA
    J Natl Cancer Inst; 1972 May; 48(5):1403-7. PubMed ID: 4337911
    [No Abstract]   [Full Text] [Related]  

  • 22. Factor time for active immunotherapy after cytoreductive chemotherapy.
    Amiel JL; Berardet M
    Eur J Cancer (1965); 1974 Feb; 10(2):89-91. PubMed ID: 4611771
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of pretreatment of mice with BCG cell walls in saline on subsequent vaccination with BCG oil droplet vaccine.
    Meyer TJ; Anacker RL; Ribi E
    Cell Immunol; 1974 Oct; 14(1):52-65. PubMed ID: 4219589
    [No Abstract]   [Full Text] [Related]  

  • 24. The significance of macrophages in human and experimental tumors.
    Alexander P; Eccles SA; Gauci CL
    Ann N Y Acad Sci; 1976; 276():124-33. PubMed ID: 800321
    [No Abstract]   [Full Text] [Related]  

  • 25. Leukemia virus-induced immunosuppression. IX. Depression of delayed hypersensitivity and MIF production after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1973 Dec; 111(6):1810-9. PubMed ID: 4584404
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental study on evaluation of BCG-immunity in mice by airborne infection].
    Toyohara M; Shimoide H
    Kekkaku; 1969 Jul; 44(7):203-6. PubMed ID: 4899861
    [No Abstract]   [Full Text] [Related]  

  • 27. Susceptibility and resistance to Friend leukemia virus: effect on production of migration-inhibition factor.
    Mortensen RF; Ceglowski WS; Friedman H
    J Natl Cancer Inst; 1974 Feb; 52(2):499-505. PubMed ID: 4593140
    [No Abstract]   [Full Text] [Related]  

  • 28. Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus.
    Starec M; Rouveix B; Sinet M; Chau F; Desforges B; Pocidalo JJ; Lechat P
    J Pharmacol Exp Ther; 1991 Nov; 259(2):745-50. PubMed ID: 1941622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neutralization bioassay for Friend leukemia virus].
    Basombrío MA; Genovese J
    Medicina (B Aires); 1978; 38(3):245-9. PubMed ID: 692359
    [No Abstract]   [Full Text] [Related]  

  • 30. [Influence of the inoculation route on residual virulence of different substrains of BCG for albino mice].
    Palhano Junior L; Gontijo Filho PP
    Rev Inst Med Trop Sao Paulo; 1980; 22(1):15-9. PubMed ID: 7001603
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of treatment of C57BL-6 mice with the methanol extraction residue fraction of BCG on leukemogenesis induced by the radiation leukemia virus.
    Haran-Ghera N; Weiss DW
    J Natl Cancer Inst; 1973 Jan; 50(1):229-34. PubMed ID: 4348221
    [No Abstract]   [Full Text] [Related]  

  • 32. BCG immunotherapy in Burkitt's lymphoma: preliminary results of a randomized clinical trial.
    Ziegler JL; Magrath IT
    Natl Cancer Inst Monogr; 1973 Dec; 39():199-202. PubMed ID: 4595317
    [No Abstract]   [Full Text] [Related]  

  • 33. Friend Leukemia Virus (FLV) activity in certain arthropods. II. Quantitative infectivity determinations.
    Rehácek J; Fischer RG; Luecke DH
    Neoplasma; 1973; 20(2):147-58. PubMed ID: 4145300
    [No Abstract]   [Full Text] [Related]  

  • 34. Virus tumorigenesis and immunity: influence of immunostimulation and immunodepression.
    Friedman H; Ceglowski WS
    Johns Hopkins Med J Suppl; 1974; 3():187-209. PubMed ID: 4609083
    [No Abstract]   [Full Text] [Related]  

  • 35. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
    Mathé G; Halle-Pannenko O; Bourut C
    Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of sensitization with bacterial antigens on the replication of Friend spleen focus-forming virus.
    Flickinger JT; Gentile JM
    Can J Microbiol; 1971 Apr; 17(4):481-6. PubMed ID: 5553350
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro induction of cell-mediated immunity to murine leukemia cells. VII. Methods for augmenting the induction and expression of cytotoxic response in vitro to syngeneic tumors.
    Kedar E; Lupu T; Schwartzbach M; Avraham Y
    J Immunol Methods; 1979; 26(2):157-71. PubMed ID: 155712
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 39. Friend Leukemia Virus (FLV) activity in certain arthropods. I. Introduction, parameters and control measures necessary for evaluation of extrinsic incubation potential.
    Luecke DH; Rehácek J; Fischer RG
    Neoplasma; 1973; 20(2):133-45. PubMed ID: 4145299
    [No Abstract]   [Full Text] [Related]  

  • 40. Biochemical aspects of leukemia virus-induced immunosuppression: effect of Friend disease virus on spleen nucleases and nucleic acids.
    Chakrabarty AK; Friedman H; Ceglowski WS
    Cancer Res; 1970 Mar; 30(3):617-24. PubMed ID: 5425287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.